ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR)

    J. Choi,1 O. Aubert,2 S. Louie,1 N. Ammerman,1 A. Vo,1 A. Peng,1 E. Huang,1 R. Najjar,1 D. Puliyanda,1 S. Sethi,1 M. Haas,1 K. Lim,1 A. Loupy,2 S. Jordan.1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Paris Translational Center for Organ Transplantation, Paris, France.

    Introduction: Disruption of the IL-6/IL-6R pathways may have benefits in treating allograft rejection. We reported our experience with anti-IL-6R (TCZ) as a treatment for CABMR…
  • 2018 American Transplant Congress

    Modifiable Causes of Racial Disparities in Living Donor Kidney Transplant

    J. Beaumont,1 J. Peipert,1,2 C. Anderson,2 A. Paiva,3 M. Robbins,3 A. Waterman.1,2

    1Terasaki Research Institute, Los Angeles, CA; 2Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA; 3Department of Psychology, University of Rhode Island, Kingston, RI.

    Racial disparities between White and non-White patients in receiving living donor kidney transplants (LDKT) are large and widespread. Yet, the causes of this disparity are…
  • 2018 American Transplant Congress

    Evaluating the Impact of Pre-Transplant Malignancy on Outcomes after Kidney Transplantation: A National Database Analysis over a Twenty-Two Year Period

    D. Livingston-Rosanoff, L. Wilke, G. Leverson, D. Foley.

    Dept. of Surgery, University of Wisconsin, Madison, WI.

    Introduction: Patients with a history of malignancy prior to kidney transplantation are known to develop more post-transplant malignancies and have inferior outcomes. However, there have…
  • 2018 American Transplant Congress

    Effect of Acute Vascular Inflammation (v) on Death Censored Graft Failure (DCGF) Following Kidney Transplant (KTx)

    J. Grande,1 L. Hunsicker,2 R. LeDuc,3 A. Matas, The DeKAF Consortium.

    1Pathology, Mayo Clinic, Rochester, MN; 2Int. Med., U Iowa, Iowa City, IA; 3Biostatistics and Surgery, U Minnesota, Minneapolis, MN.

    The impact of acute vascular inflammation in acute cellular or humoral rejection following KTx, and the effect of isolated vascular inflammatory lesions on late DCGF,…
  • 2018 American Transplant Congress

    Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes

    H. Yamout,1,2 R. Ouseph,1 M. Schnitzler,1 H. Xiao,1 V. Dharnidharka,3 A. Naik,4 N. Lam,5 F. Koraishy,1,2 H. Randall,1 D. Brennan,6 D. Segev,6 B. Kasiske,7 G. Hess,8 K. Lentine.1

    1Saint Louis Univ, St. Louis; 2St. Louis VA, St. Louis; 3Washington Univ, St. Louis; 4Univ Michigan, Ann Arbor, Canada; 5Univ Alberta, Edmonton; 6Johns Hopkins, Baltimore; 7Hennepin County, Minneapolis; 8Symphony Health, Conshohocken.

    Hypertension is common among kidney transplant (KTx) recipients, but the impact of antihypertensive medication (AHM) choice on patient and graft outcomes is not well defined.We…
  • 2018 American Transplant Congress

    Development of an Individualized Online Shared Decision Making Tool for Kidney Transplant Candidates

    A. Hart,1,2,3 M. Bruin,1 S. Chu,1 M. Partin,1 A. Matas,1 C. John,1 A. Israni.1,2,3

    1University of Minnesota, Minneapolis; 2Scientific Registry of Transplant Recipients, Minneapolis; 3Hennepin County Medical Center, Minneapolis.

    Background: Inadequate knowledge hinders informed decision making in kidney transplant candidates. We conducted qualitative interviews and focus groups with patients and providers to inform development…
  • 2018 American Transplant Congress

    Impact of Rapid Discontinuation of Prednisone on Kidney Transplant Outcomes in At-Risk Subpopulations: An OPTN/SRTR Analysis

    D. Vock,1 A. Matas.2

    1Public Health, U of MN, Mpls, MN; 2Surgery, U of MN, Mpls, MN.

    Objective: Successful RDP (rapid discontinuation of prednisone <1 week post-tx) after kidney transplant (KTx) has been reported for low-risk populations. We studied the impact of…
  • 2018 American Transplant Congress

    Non-Invasive Diagnostic of Renal Allograft Rejection via Urine Metabolites Using NMR-Spectroscopy

    M. Banas,1 S. Neumann,2 P. Pagel,2 D. Chittka,1 V. Pfahlert,2 B. Banas.1

    1Department of Nephrology, University Hospital Regensburg, Regensburg, Germany; 2numares HEALTH, Regensburg, Germany.

    Introduction and BackgroundPost-transplant surveillance for acute rejection is typically based on regular monitoring of serum creatinine levels and consecutive biopsies upon functional renal impairment. Attempts…
  • 2018 American Transplant Congress

    Presence of Donor Specific Antibodies is Associated with Accelerated Podocyte Detachment

    A. Naik, J. Aqeel, D. Cibrik, M. Samaniego, S. Wang, M. Chowdhury, F. Afshinnia, R. Wiggins.

    University of Michigan, Ann Arbor; University of Kansas, Kansas City.

    Introduction: Both indication and 10-yr surveillance biopsy data point to the important role of progressive glomerular disease in intermediate and long-term allograft outcomes. As all…
  • 2018 American Transplant Congress

    TORC1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

    B. Al Dulaijan, S. Eskandari, J. Karnyski, J. Assaker, S. Cai, A. Mansouri, M. Mohamed, J. Azzi.

    Transplantation Research Center, BWH, Harvard Medical School, Boston, MA.

    The safety and efficacy of adoptive transfer of regulatory T cells (Tregs) are being extensively investigated in ongoing clinical trials. However, these trials have been…
  • « Previous Page
  • 1
  • …
  • 249
  • 250
  • 251
  • 252
  • 253
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences